A citation-based method for searching scientific literature

B Wang, J Zhong, H Lin, Z Zhao, Z Yan, H He, Y Ni, D Liu, Z Zhu. Diabetes Obes Metab 2013
Times Cited: 126



Keith C Ferdinand, William B White, David A Calhoun, Eva M Lonn, Philip T Sager, Rocco Brunelle, Honghua H Jiang, Rebecca J Threlkeld, Kenneth E Robertson, Mary Jane Geiger. Hypertension 2014
Times Cited: 83




List of shared articles



Times cited

Blood Pressure-Lowering Effect of Newer Antihyperglycemic Agents (SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors).
Charalampos I Liakos, Dimitrios P Papadopoulos, Elias A Sanidas, Maria I Markou, Erifili E Hatziagelaki, Charalampos A Grassos, Maria L Velliou, John D Barbetseas. Am J Cardiovasc Drugs 2021
1


Blood pressure control in type 2 diabetes mellitus with arterial hypertension. The important ancillary role of SGLT2-inhibitors and GLP1-receptor agonists.
C Berra, R Manfrini, D Regazzoli, M G Radaelli, O Disoteo, C Sommese, P Fiorina, G Ambrosio, F Folli. Pharmacol Res 2020
5

An overview of glucagon-like peptide-1 receptor agonists for the treatment of metabolic syndrome: A drug repositioning.
Maryam Rameshrad, Bibi Marjan Razavi, Jean-Daniel Lalau, Marc E De Broe, Hossein Hosseinzadeh. Iran J Basic Med Sci 2020
2

Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force.
Sanjay Kalra, Ashok Kumar Das, Rakesh Kumar Sahay, Manash Pratim Baruah, Mangesh Tiwaskar, Sambit Das, Sudip Chatterjee, Banshi Saboo, Ganapathi Bantwal, Saptarshi Bhattacharya,[...]. Diabetes Ther 2019
8

Gastrointestinal-Renal Axis: Role in the Regulation of Blood Pressure.
Jian Yang, Pedro A Jose, Chunyu Zeng. J Am Heart Assoc 2017
19


Cardiovascular Effects of Incretin-Based Therapies.
William B White, William L Baker. Annu Rev Med 2016
19

GLP-1 Agonists and Blood Pressure: A Review of the Evidence.
Aditya Goud, Jixin Zhong, Matthew Peters, Robert D Brook, Sanjay Rajagopalan. Curr Hypertens Rep 2016
37